Oorja Bio
Company
Oorja Bio develops one asset, in phase 2 (ORJ-001 in idiopathic pulmonary fibrosis). Mostly other.
- 1
- Asset
- Furthest stage
- Phase 2
- 1
- Trial
- 2
- Signals
Pipeline
1Phase 2, Other, idiopathic pulmonary fibrosis
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials1
- Signals2
- Similar companies6